Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,869 | 490 | 99.5% |
| Education | $31.52 | 4 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,403 | 109 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $712.53 | 55 | $0 (2023) |
| PFIZER INC. | $559.78 | 46 | $0 (2024) |
| GlaxoSmithKline, LLC. | $517.71 | 36 | $0 (2023) |
| Lilly USA, LLC | $512.15 | 41 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $386.42 | 27 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $356.58 | 24 | $0 (2024) |
| ABBVIE INC. | $243.67 | 16 | $0 (2024) |
| Amgen Inc. | $203.26 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $170.58 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $683.76 | 40 | AstraZeneca Pharmaceuticals LP ($155.95) |
| 2023 | $578.78 | 33 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($86.25) |
| 2022 | $474.09 | 29 | Janssen Pharmaceuticals, Inc ($80.75) |
| 2021 | $622.56 | 44 | Janssen Pharmaceuticals, Inc ($124.29) |
| 2020 | $785.08 | 57 | Novo Nordisk Inc ($193.57) |
| 2019 | $1,004 | 73 | Novo Nordisk Inc ($240.12) |
| 2018 | $1,210 | 95 | Novo Nordisk Inc ($306.36) |
| 2017 | $1,543 | 123 | Novo Nordisk Inc ($411.50) |
All Payment Transactions
494 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: VACCINES | ||||||
| 11/26/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/28/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: VACCINES | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Respiratory | ||||||
| 08/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: VACCINES | ||||||
| 07/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Gastroenterology | ||||||
| 06/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: NEUROSCIENCE | ||||||
| 05/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,155 | 3,283 | $472,121 | $165,967 |
| 2022 | 19 | 1,772 | 2,958 | $354,653 | $118,644 |
| 2021 | 19 | 1,956 | 3,031 | $342,604 | $127,947 |
| 2020 | 20 | 1,602 | 2,589 | $302,841 | $99,516 |
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 464 | 1,128 | $306,660 | $97,732 | 31.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 250 | 250 | $72,774 | $32,050 | 44.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 52 | 63 | $28,371 | $10,195 | 35.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 89 | 89 | $15,575 | $6,402 | 41.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 576 | 797 | $14,757 | $4,823 | 32.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 106 | 108 | $5,076 | $3,256 | 64.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 248 | 380 | $4,240 | $2,850 | 67.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 139 | 139 | $5,775 | $2,553 | 44.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 35 | 37 | $4,446 | $1,481 | 33.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 31 | 34 | $3,948 | $1,325 | 33.6% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 18 | 33 | $2,950 | $918.12 | 31.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 17 | $3,271 | $884.47 | 27.0% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 18 | 19 | $1,500 | $630.73 | 42.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 33 | 57 | $1,770 | $567.46 | 32.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 44 | 66 | $396.00 | $145.20 | 36.7% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 20 | 24 | $396.00 | $108.31 | 27.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 16 | 42 | $216.00 | $45.82 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 354 | 972 | $258,219 | $80,774 | 31.3% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 45 | 59 | $24,933 | $9,305 | 37.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 622 | 915 | $15,940 | $5,614 | 35.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 60 | 60 | $8,820 | $4,112 | 46.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 31 | 31 | $8,537 | $4,094 | 48.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 62 | 71 | $13,123 | $2,842 | 21.7% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 44 | 49 | $5,620 | $2,324 | 41.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 78 | 79 | $3,713 | $2,321 | 62.5% |
About Dr. Jonathan Swank, MD
Dr. Jonathan Swank, MD is a Internal Medicine healthcare provider based in Abingdon, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750459228.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Swank, MD has received a total of $6,901 in payments from pharmaceutical and medical device companies, with $683.76 received in 2024. These payments were reported across 494 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($6,869).
As a Medicare-enrolled provider, Swank has provided services to 7,485 Medicare beneficiaries, totaling 11,861 services with total Medicare billing of $512,074. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Abingdon, VA
- Active Since 12/01/2006
- Last Updated 01/05/2026
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1750459228
Products in Payments
- XARELTO (Drug) $680.60
- Ozempic (Drug) $584.78
- XIFAXAN (Drug) $412.42
- TRULICITY (Drug) $315.38
- Victoza (Drug) $310.62
- Saxenda (Drug) $285.04
- ANORO (Drug) $232.84
- ELIQUIS (Drug) $194.20
- CHANTIX (Drug) $188.47
- PREVNAR 20 (Biological) $173.58
- BREZTRI (Drug) $157.28
- Vascepa (Drug) $152.56
- MOUNJARO (Drug) $151.08
- ENTRESTO (Drug) $133.69
- JANUVIA (Drug) $131.02
- FARXIGA (Drug) $129.16
- BREO (Drug) $109.22
- SYNTHROID (Drug) $96.59
- NEXLETOL (Drug) $92.84
- Amitiza (Drug) $88.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Abingdon
Emory Robinette, M.d, M.D
Internal Medicine — Payments: $66,893
Clinton Sutherland, Md, MD
Internal Medicine — Payments: $30,337
Haytham Adada, Md, MD
Internal Medicine — Payments: $10,638
Robert Jones, M.d, M.D
Internal Medicine — Payments: $10,385
Dr. William Baker, Md, MD
Internal Medicine — Payments: $4,876
Moe Mya, M.d, M.D
Internal Medicine — Payments: $4,505